Surgical Science Sweden AB (SUS) — Cash Flow Reinvestment Rate
Surgical Science Sweden AB (SUS) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting Skr6.24 Million (capex Skr6.24 Million ) from operating cash flow of Skr72.89 Million. Explore Surgical Science Sweden AB (SUS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Surgical Science Sweden AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Surgical Science Sweden AB across 11 annual periods. Also explore Surgical Science Sweden AB balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Surgical Science Sweden AB (2015–2025)
Year-by-year capital reinvestment analysis for Surgical Science Sweden AB. For live market cap and broader valuation context, see SUS stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | Skr11.68 Million | Skr79.80 Million | Skr11.68 Million | ▼ -78.9% |
| 2024 | 0.69x | Skr95.06 Million | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.37x | Skr88.26 Million | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.53x | Skr69.10 Million | Skr129.49 Million | Skr34.55 Million | ▼ -99.2% |
| 2021 | 70.29x | Skr2.75 Billion | Skr39.08 Million | Skr14.38 Million | ▲ +9288.1% |
| 2020 | 0.75x | Skr17.39 Million | Skr23.23 Million | Skr8.69 Million | ▼ -81.1% |
| 2019 | 3.97x | Skr219.22 Million | Skr55.20 Million | Skr8.91 Million | ▲ +58.1% |
| 2018 | 2.51x | Skr17.27 Million | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 3.05x | Skr24.23 Million | Skr7.94 Million | Skr12.12 Million | ▲ +249.7% |
| 2016 | 0.87x | Skr11.70 Million | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr8.30 Million | Skr7.50 Million | Skr8.30 Million | — |